Adalimumab-induced lupus serositis

BMJ Case Rep. 2015 Mar 4:2015:bcr2014207323. doi: 10.1136/bcr-2014-207323.

Abstract

A 61-year-old man presented with a 1-month history of breathlessness, chest pain and lethargy. He had been taking adalimumab for ankylosing spondylitis for 2 years. Pleural and pericardial effusions were both found. A video-assisted thorascopic (VATS) pleural and lung biopsy were performed. The pleural pathology showed eosinophils, acute inflammatory cells and lymphoid aggregates. The patient was positive for antinuclear, antidouble-stranded and antihistone antibodies consistent with drug-induced lupus due to adalimumab. His serositis resolved on withdrawal of the drug. Drug-induced lupus can occur as a consequence of anti-TNF-α agents from induction of autoimmunity in a predisposed host.

Publication types

  • Case Reports

MeSH terms

  • Adalimumab / adverse effects*
  • Anti-Inflammatory Agents / adverse effects*
  • Cardiomegaly / chemically induced
  • Humans
  • Male
  • Middle Aged
  • Pericardial Effusion / chemically induced*
  • Pleural Effusion / chemically induced*
  • Serositis / chemically induced*
  • Spondylitis, Ankylosing / drug therapy
  • Withholding Treatment

Substances

  • Anti-Inflammatory Agents
  • Adalimumab